Swedbank AB Purchases 33,940 Shares of Astera Labs, Inc. $ALAB

Swedbank AB increased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 76.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 78,140 shares of the company’s stock after acquiring an additional 33,940 shares during the period. Swedbank AB’s holdings in Astera Labs were worth $12,999,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares in the last quarter. Amundi raised its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC bought a new position in shares of Astera Labs during the third quarter valued at $209,599,000. BNP Paribas Financial Markets boosted its position in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new stake in shares of Astera Labs during the third quarter valued at $131,539,000. 60.47% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,064,888 shares of company stock valued at $150,764,723 in the last 90 days. 12.50% of the stock is owned by insiders.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ALAB shares. Roth Mkm reissued a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday. Citigroup raised their price target on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday. Stifel Nicolaus lifted their price target on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday. Jefferies Financial Group reissued a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a report on Wednesday. Finally, TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $229.65.

Astera Labs Stock Performance

Astera Labs stock opened at $199.79 on Friday. Astera Labs, Inc. has a one year low of $69.26 and a one year high of $262.90. The stock has a fifty day moving average of $143.77 and a 200 day moving average of $153.99. The stock has a market cap of $34.25 billion, a PE ratio of 134.99, a price-to-earnings-growth ratio of 3.30 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the company posted $0.33 EPS. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.